greatwestpay

Peptide merchants often face payment declines because mainstream processors see their business as risky. The product type, the way it is marketed, and the rules around compliance can all trigger a rejection. That is why many peptide businesses need a more flexible payment partner like Great West Pay . What Makes Peptide Merchants High Risk? Mainstream processors want simple, low-risk businesses. They prefer products that do not create legal, medical, or chargeback concerns. Peptides often fall into a gray area, so banks and processors become careful fast. Some peptide sellers market products for research only. Others operate in wellness or telehealth spaces. This mix can confuse underwriters. When a business looks unclear, the processor often says no. Regulatory Uncertainty Creates Fear One major reason for declines is regulation. Peptides may be linked to health, wellness, sports, or research. That makes the business model harder to review. If a processor cannot quickly understand t...